Update app.py
Browse files
app.py
CHANGED
@@ -5,27 +5,29 @@ st.set_page_config(layout="wide")
|
|
5 |
st.markdown("""
|
6 |
## Anatomy 101 with Health Care Costs:
|
7 |
|
8 |
-
| Table Num | Body Part | Organ/Part | Description
|
9 |
-
|
10 |
-
| 1 | π§ Head | π§ Brain | Controls mental processes
|
11 |
-
| 2 | π Eyes | ποΈ Optic Nerve | Vision
|
12 |
-
| 3 | π Ears | π Cochlea | Hearing
|
13 |
-
| 4 | π Nose | π Olfactory Bulb | Smell
|
14 |
-
| 5 | π Mouth | π
Tongue | Taste
|
15 |
-
| 6 | π« Neck | π¦ Thyroid | Metabolism
|
16 |
-
| 7 | πͺ Upper Body | β€οΈ Heart | Circulation
|
17 |
-
| 8 | πͺ Upper Body | π« Lungs | Respiration
|
18 |
-
| 9 | πͺ Upper Body | π½οΈ
|
19 |
-
| 10 | πͺ Upper Body | π· Liver | Detoxification
|
20 |
-
| 11 | πͺ Upper Body | πΉ Kidneys | Filtration
|
21 |
-
| 12 | πͺ Upper Body |
|
22 |
-
| 13 | πͺ Upper Body |
|
23 |
-
| 14 |
|
24 |
-
| 15 | 𦡠Lower Body |
|
25 |
-
| 16 | 𦡠Lower Body |
|
26 |
-
| 17 |
|
27 |
-
| 18 | π¦Ά Feet |
|
28 |
-
| 19 | π¦Ά Feet |
|
29 |
-
| 20 |
|
|
|
|
|
30 |
|
31 |
""")
|
|
|
5 |
st.markdown("""
|
6 |
## Anatomy 101 with Health Care Costs:
|
7 |
|
8 |
+
| Table Num | Body Part | Organ/Part | Description | π Costly Condition | π° Spending (billions) | CPT Range Start | CPT Range Finish | Frequency |
|
9 |
+
|-----------|------------------|----------------------|-------------------------------|------------------------------|------------------------|-----------------|------------------|----------------|
|
10 |
+
| 1 | π§ Head | π§ Brain | Controls mental processes | π¨ Anxiety & Depression | 210 | 90791 | 90899 | 1 in 5 |
|
11 |
+
| 2 | π Eyes | ποΈ Optic Nerve | Vision | π Cataracts | 10.7 | 92002 | 92499 | 1 in 6 (over 40 years) |
|
12 |
+
| 3 | π Ears | π Cochlea | Hearing | π’ Hearing Loss | 7.1 | 92502 | 92700 | 1 in 8 (over 12 years) |
|
13 |
+
| 4 | π Nose | π Olfactory Bulb | Smell | π€§ Allergies | 25 | 31231 | 31294 | 1 in 3 |
|
14 |
+
| 5 | π Mouth | π
Tongue | Taste | π¦· Dental Issues | 130 | 00100 | 00192 | 1 in 2 |
|
15 |
+
| 6 | π« Neck | π¦ Thyroid | Metabolism | π¦ Hypothyroidism | 3.1 | 60210 | 60271 | 1 in 20 |
|
16 |
+
| 7 | πͺ Upper Body | β€οΈ Heart | Circulation | π Heart Disease | 230 | 92920 | 93799 | 1 in 4 (over 65 years) |
|
17 |
+
| 8 | πͺ Upper Body | π« Lungs | Respiration | π· Chronic Obstructive Pulmonary Disease | 70 | 94002 | 94799 | 1 in 20 (over 45 years) |
|
18 |
+
| 9 | πͺ Upper Body | π½οΈ Esophagus | Passage of food | π₯ Gastroesophageal Reflux Disease | 17 | 43200 | 43289 | 1 in 5 |
|
19 |
+
| 10 | πͺ Upper Body | π· Liver | Detoxification | πΊ Liver Disease | 40 | 47000 | 47999 | 1 in 10 |
|
20 |
+
| 11 | πͺ Upper Body | πΉ Kidneys | Filtration | π Chronic Kidney Disease | 110 | 50010 | 50999 | 1 in 7 |
|
21 |
+
| 12 | πͺ Upper Body | π Pancreas | Insulin secretion | π¬ Diabetes | 327 | 48100 | 48999 | 1 in 10 |
|
22 |
+
| 13 | πͺ Upper Body | π‘οΈ Spleen | Immune functions | π©Έ Anemia | 5.6 | 38100 | 38199 | 1 in 6 |
|
23 |
+
| 14 | 𦡠Lower Body | π Colon | Absorption of water, minerals | π Colorectal Cancer | 14 | 45378 | 45378 | 1 in 23 |
|
24 |
+
| 15 | 𦡠Lower Body | π½ Bladder | Urine excretion | π§ Urinary Incontinence | 8 | 51700 | 51798 | 1 in 4 (over 65 years) |
|
25 |
+
| 16 | 𦡠Lower Body | π Reproductive Organs | Sex hormone secretion | ποΈ Endometriosis | 22 | 56405 | 58999 | 1 in 10 (women) |
|
26 |
+
| 17 | π¦Ά Feet | π― Nerve endings | Balance and movement | π€ Peripheral Neuropathy | 19 | 95900 | 96004 | 1 in 30 |
|
27 |
+
| 18 | π¦Ά Feet | π‘οΈ Skin | Temperature regulation | π Skin Cancer | 8.1 | 96910 | 96999 | 1 in 5 |
|
28 |
+
| 19 | π¦Ά Feet | πͺ Muscles | Movement and strength | ποΈββοΈ Musculoskeletal Disorders | 176 | 97110 | 97799 | 1 in 2 |
|
29 |
+
| 20 | πͺ Upper Body | π« Esophagus | Passage of food | π₯ Gastroesophageal Reflux Disease (GERD) | Considerable | Specific to GERD | Specific to GERD | Very Common |
|
30 |
+
|
31 |
+
Note: For "Colorectal Cancer" and "Gastroesophageal Reflux Disease (GERD)," specific spending and CPT range values need to be adjusted based on the latest data, which may require further research. The frequency and impact of these conditions make them more aligned with the table's intent of highlighting high-cost and high-prevalence conditions.
|
32 |
|
33 |
""")
|